US senator alleges FDA tried to prevent Adderall XR withdrawal in Canada.
Eggertson
Laura
L
D000328:Adult; D000662:Amphetamines / Q000009:adverse effects*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D002170:Canada; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D002648:Child; D004335:Drug and Narcotic Control; D006801:Humans; D009313:National Health Programs; D015279:Organizational Culture; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration
D000662:Amphetamines; D000697:Central Nervous System Stimulants; C449521:SLI381